Ombretta Lenzi

发表

Developing new 4-PIOL and 4-PHP analogues for photo-inactivation of γ-aminobutyric acid type A receptors.

A. A. Jensen, T. Smart, B. Frølund, 2019, ACS chemical neuroscience.

4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

S. Moro, Erika Morizzo, C. Martini, 2006, Journal of medicinal chemistry.

Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure-activity relationships.

C. Costagli, A. Galli, Ombretta Lenzi, 2008, Bioorganic & medicinal chemistry.

Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.

C. Costagli, A. Galli, F. R. Calabri, 2005, European journal of medicinal chemistry.

Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

S. Moro, Erika Morizzo, F. Pedata, 2009, Journal of medicinal chemistry.

1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.

S. Moro, F. Deflorian, C. Martini, 2004, Journal of medicinal chemistry.

1,2,4-Triazolo[1,5-a]quinoxaline as a Versatile Tool for the Design of Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Biological Evaluation, and Molecular Modeling Studies of 2-(Hetero)aryl- and 2-Carboxy-Substitued Derivatives

S. Moro, C. Martini, L. Trincavelli, 2005 .

1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study.

S. Moro, F. Deflorian, C. Costagli, 2005, Bioorganic & medicinal chemistry.

Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.

S. Moro, F. Deflorian, C. Ghelardini, 2006, Journal of medicinal chemistry.

Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.

K. Varani, G. Cristalli, F. Vincenzi, 2011, Bioorganic & medicinal chemistry.

New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

S. Moro, Erika Morizzo, F. Pedata, 2007, Journal of medicinal chemistry.

Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.

K. Lingenhöhl, S. Ofner, Ombretta Lenzi, 2010, Chemical & pharmaceutical bulletin.

Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.

S. Moro, Erika Morizzo, F. Pedata, 2008, Bioorganic & medicinal chemistry.

1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.

S. Moro, C. Martini, L. Trincavelli, 2005, Journal of medicinal chemistry.

Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies.

K. Varani, G. Cristalli, F. Vincenzi, 2009, Bioorganic & medicinal chemistry.

Allergic contact dermatitis from depilatory wax.

P. Pigatto, Ombretta Lenzi, G. Ermini, 2012, Dermatitis : contact, atopic, occupational, drug.

3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies.

S. Moro, F. Pedata, Davide Sabbadin, 2012, European journal of medicinal chemistry.

2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.

S. Moro, Erika Morizzo, K. Varani, 2009, Journal of medicinal chemistry.

Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study.

S. Moro, Erika Morizzo, K. Varani, 2007, Journal of medicinal chemistry.

2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.

S. Moro, C. Martini, F. R. Calabri, 2005, Bioorganic & medicinal chemistry.